Apolipoprotein L1-associated Nephropathy and the Future of Renal Diagnostics

Overview

Journal J Am Soc Nephrol

Specialty Nephrology

Date 2015 Jan 10

PMID 25573910

Citations 10

Authors

Christopher P Larsen

Barry I Freedman

Affiliations

Soon will be listed here.

Citing Articles

Brown-Norway chromosome 1 mitigates the upregulation of proinflammatory pathways in mTAL cells and subsequent age-related CKD in Dahl SS/JrHsdMcwi rats.

Chivers J, Whiles S, Miles C, Biederman B, Ellison M, Lovingood C Am J Physiol Renal Physiol. 2022; 324(2):F193-F210.

PMID: 36475869 PMC: 9886360. DOI: 10.1152/ajprenal.00145.2022.

Is podocytopathy another image of renal affection in p-SLE?.

Abdelnabi H Pediatr Rheumatol Online J. 2021; 19(1):57.

PMID: 33902643 PMC: 8077747. DOI: 10.1186/s12969-021-00547-9.

Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.

Kumar V, Vashistha H, Lan X, Chandel N, Ayasolla K, Marashi Shoshtari S Am J Pathol. 2018; 188(11):2508-2528.

PMID: 30201495 PMC: 6222279. DOI: 10.1016/j.ajpath.2018.07.025.

APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Beckerman P, Susztak K Trends Mol Med. 2018; 24(8):682-695.

PMID: 29886044 PMC: 6101980. DOI: 10.1016/j.molmed.2018.05.008.

Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Ku E, Lipkowitz M, Appel L, Parsa A, Gassman J, Glidden D Kidney Int. 2016; 91(2):443-450.

PMID: 27927600 PMC: 5237400. DOI: 10.1016/j.kint.2016.09.033.

References

Freedman B, Skorecki K . Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. Clin J Am Soc Nephrol. 2014; 9(11):2006-13. PMC: 4220749. DOI: 10.2215/CJN.01330214. View

Giglio S, Provenzano A, Mazzinghi B, Becherucci F, Giunti L, Sansavini G . Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol. 2014; 26(1):230-6. PMC: 4279734. DOI: 10.1681/ASN.2013111155. View

Larsen C, Beggs M, Saeed M, Ambruzs J, Cossey L, Messias N . Histopathologic findings associated with APOL1 risk variants in chronic kidney disease. Mod Pathol. 2014; 28(1):95-102. PMC: 11163378. DOI: 10.1038/modpathol.2014.92. View

Nichols B, Jog P, Lee J, Blackler D, Wilmot M, DAgati V . Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2014; 87(2):332-42. PMC: 4312530. DOI: 10.1038/ki.2014.270. View

Kopp J, Winkler C, Zhao X, Radeva M, Gassman J, DAgati V . Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. J Am Soc Nephrol. 2015; 26(6):1443-8. PMC: 4446865. DOI: 10.1681/ASN.2013111242. View

DAgati V, Fogo A, Bruijn J, Jennette J . Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004; 43(2):368-82. DOI: 10.1053/j.ajkd.2003.10.024. View

Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

Reeves-Daniel A, DePalma J, Bleyer A, Rocco M, Murea M, Adams P . The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011; 11(5):1025-30. PMC: 3083491. DOI: 10.1111/j.1600-6143.2011.03513.x. View

Atta M, Estrella M, Kuperman M, Foy M, Fine D, Racusen L . HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int. 2012; 82(3):338-43. PMC: 3463138. DOI: 10.1038/ki.2012.111. View

10.

Johnstone D, Shegokar V, Nihalani D, Rathore Y, Mallik L, Ashish . APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS One. 2013; 7(12):e51546. PMC: 3530541. DOI: 10.1371/journal.pone.0051546. View

11.

Larsen C, Beggs M, Saeed M, Walker P . Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol. 2013; 24(5):722-5. PMC: 3636799. DOI: 10.1681/ASN.2012121180. View

12.

DAgati V, Mengel M . The rise of renal pathology in nephrology: structure illuminates function. Am J Kidney Dis. 2013; 61(6):1016-25. DOI: 10.1053/j.ajkd.2012.12.019. View

13.

Divers J, Nunez M, High K, Murea M, Rocco M, Ma L . JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int. 2013; 84(6):1207-13. PMC: 3844025. DOI: 10.1038/ki.2013.173. View

14.

Freedman B, Langefeld C, Andringa K, Croker J, Williams A, Garner N . End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014; 66(2):390-6. PMC: 4002759. DOI: 10.1002/art.38220. View

15.

Divers J, Palmer N, Lu L, Langefeld C, Rocco M, Hicks P . Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant. 2013; 29(3):587-94. PMC: 3938297. DOI: 10.1093/ndt/gft423. View

16.

Lan X, Jhaveri A, Cheng K, Wen H, Saleem M, Mathieson P . APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol. 2014; 307(3):F326-36. PMC: 4121568. DOI: 10.1152/ajprenal.00647.2013. View